Measurement of ADA levels is routine in the detection of clinical hepatic function, and recent studies have shown that it has a potential role in the assessment of metabolic diseases, inflammatory diseases, cardiovascular diseases and so on. This evidence concerns the gene ADA and cardiovascular disorder.